| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥333.38B | ¥310.03B | +7.5% |
| Cost of Sales | ¥304.07B | ¥282.02B | +7.8% |
| Gross Profit | ¥29.32B | ¥28.01B | +4.7% |
| SG&A Expenses | ¥21.14B | ¥20.26B | +4.3% |
| Operating Income | ¥8.18B | ¥7.74B | +5.6% |
| Non-operating Income | ¥951M | ¥1.47B | -35.2% |
| Non-operating Expenses | ¥407M | ¥796M | -48.9% |
| Ordinary Income | ¥8.72B | ¥8.41B | +3.7% |
| Profit Before Tax | ¥8.62B | ¥8.39B | +2.8% |
| Income Tax Expense | ¥3.23B | ¥3.07B | +5.2% |
| Net Income | ¥5.39B | ¥5.32B | +1.4% |
| Net Income Attributable to Owners | ¥5.43B | ¥5.54B | -1.9% |
| Total Comprehensive Income | ¥6.35B | ¥5.22B | +21.8% |
| Depreciation & Amortization | ¥2.67B | ¥2.72B | -1.8% |
| Interest Expense | ¥229M | ¥250M | -8.4% |
| Basic EPS | ¥58.00 | ¥58.71 | -1.2% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥237.85B | ¥259.46B | ¥-21.61B |
| Cash and Deposits | ¥72.81B | ¥77.50B | ¥-4.69B |
| Accounts Receivable | ¥113.21B | ¥135.52B | ¥-22.30B |
| Inventories | ¥26.33B | ¥23.57B | +¥2.75B |
| Non-current Assets | ¥122.19B | ¥122.25B | ¥-51M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥11.62B | ¥6.39B | +¥5.23B |
| Investing Cash Flow | ¥-471M | ¥-2.47B | +¥2.00B |
| Financing Cash Flow | ¥-14.80B | ¥-9.16B | ¥-5.65B |
| Free Cash Flow | ¥11.15B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 1.6% |
| Gross Profit Margin | 8.8% |
| Current Ratio | 138.8% |
| Quick Ratio | 123.4% |
| Debt-to-Equity Ratio | 1.46x |
| Interest Coverage Ratio | 35.72x |
| EBITDA Margin | 3.3% |
| Effective Tax Rate | 37.4% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +7.5% |
| Operating Income YoY Change | +5.6% |
| Ordinary Income YoY Change | +3.7% |
| Net Income Attributable to Owners YoY Change | -1.9% |
| Total Comprehensive Income YoY Change | +21.7% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 94.35M shares |
| Treasury Stock | 2.22M shares |
| Average Shares Outstanding | 93.65M shares |
| Book Value Per Share | ¥1,586.59 |
| EBITDA | ¥10.85B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥58.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| DispensingPharmacy | ¥17.00B | ¥1.98B |
| LifeCare | ¥18.59B | ¥1.02B |
| MedicalSupplies | ¥247.46B | ¥2.83B |
| TotalPackProduce | ¥52.12B | ¥2.42B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥700.00B |
| Operating Income Forecast | ¥26.00B |
| Ordinary Income Forecast | ¥26.50B |
| Net Income Attributable to Owners Forecast | ¥15.50B |
| Basic EPS Forecast | ¥166.85 |
| Dividend Per Share Forecast | ¥60.00 |
| Property, Plant & Equipment | ¥58.68B | ¥58.96B | ¥-282M |
| Intangible Assets | ¥12.51B | ¥12.73B | ¥-226M |
| Goodwill | ¥7.40B | ¥7.41B | ¥-14M |
| Investment Securities | ¥30.94B | ¥29.38B | +¥1.56B |
| Total Assets | ¥360.04B | ¥381.70B | ¥-21.66B |
| Current Liabilities | ¥171.40B | ¥188.01B | ¥-16.61B |
| Accounts Payable | ¥109.12B | ¥121.67B | ¥-12.55B |
| Short-term Loans | ¥866M | ¥698M | +¥168M |
| Non-current Liabilities | ¥42.46B | ¥43.41B | ¥-952M |
| Long-term Loans | ¥29.41B | ¥30.62B | ¥-1.21B |
| Total Liabilities | ¥213.86B | ¥231.42B | ¥-17.56B |
| Total Equity | ¥146.18B | ¥150.28B | ¥-4.10B |
| Capital Stock | ¥15.55B | ¥15.55B | ¥0 |
| Capital Surplus | ¥19.42B | ¥23.57B | ¥-4.16B |
| Retained Earnings | ¥108.80B | ¥120.41B | ¥-11.61B |
| Treasury Stock | ¥-4.78B | ¥-15.53B | +¥10.75B |
| Owners' Equity | ¥145.03B | ¥149.08B | ¥-4.04B |
| Working Capital | ¥66.44B | - | - |